Neoadjuvant Chemoimmunotherapy Versus Concurrent Chemoradiotherapy for LACC

NCT06288373 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

440

Enrollment

OTHER

Sponsor class

Conditions

Cervical Cancer
Locally Advanced Cervical Cancer
Concurrent Chemoradiotherapy
Neoadjuvant Chemoimmunotherapy

Interventions

DRUG: Camrelizumab
DRUG: Cisplatin
DRUG: Nab paclitaxel
PROCEDURE: Radical surgery
RADIATION: external beam radiation therapy (EBRT) + brachytherapy
DRUG: Cisplatin

Sponsor

Tongji Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]